<DOC>
	<DOCNO>NCT00144651</DOCNO>
	<brief_summary>This open-label , extension , Phase II study evaluate long-term safety efficacy MRA Patients RA participate Study MRA009JP .</brief_summary>
	<brief_title>Study MRA Patients With Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Patients administer MRA 2 time precede study , MRA009JP , evaluate efficacy safety . Patients confirm show safety precede study . Patients Class IV Steinbrocker functional activity evaluation within 4 week treatment study drug Patients receive follow treatment start precede study registration study . 1 . Plasma exchange therapy 2 . Surgical treatment ( e.g. , operation )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>